There is a lack of evidence on the efficacy and safety of pharmacological treatments for chronic pain in children.
De facto medical use of cannabis for symptom relief is common among adult-use dispensary customers in Colorado.
While no adverse events have been reported to date, the use of this product could potentially cause serious adverse reactions.
A virtual reality treatment developed for the treatment of phantom limb pain may reduce pain intensity and phantom sensations in some patients.
Peer victimization may negatively affect mood and pain and may limit activity in youths with chronic pain.
Research has found that pathogens in the microbiome can increase pain as well as cause anxiety and depression.
Researchers conducted a double-blind study to assess the effect of naldemedine therapy vs placebo in reducing symptoms associated with opioid-induced constipation.
Opioid weaning may not predict long-term outcomes of an interdisciplinary chronic pain rehabilitation program.
Prevalence higher for those with less than high school education, low income, public insurance
Researchers evaluated the response of rifaximin therapy in patients with IBS-D with abdominal pain symptoms.